[HTML][HTML] Molecular targeted therapy for anticancer treatment
HY Min, HY Lee - Experimental & molecular medicine, 2022 - nature.com
Since the initial clinical approval in the late 1990s and remarkable anticancer effects for
certain types of cancer, molecular targeted therapy utilizing small molecule agents or …
certain types of cancer, molecular targeted therapy utilizing small molecule agents or …
[HTML][HTML] Enhancers in disease: molecular basis and emerging treatment strategies
A Claringbould, JB Zaugg - Trends in molecular medicine, 2021 - cell.com
Enhancers are genomic sequences that play a key role in regulating tissue-specific gene
expression levels. An increasing number of diseases are linked to impaired enhancer …
expression levels. An increasing number of diseases are linked to impaired enhancer …
[HTML][HTML] Epigenetics of childhood trauma: Long term sequelae and potential for treatment
KM Thumfart, A Jawaid, K Bright, M Flachsmann… - Neuroscience & …, 2022 - Elsevier
Childhood trauma (CT) can have persistent effects on the brain and is one of the major risk
factors for neuropsychiatric diseases in adulthood. Recent advances in the field of …
factors for neuropsychiatric diseases in adulthood. Recent advances in the field of …
[HTML][HTML] The impact of histone deacetylase inhibitors on immune cells and implications for cancer therapy
Many cancers possess the ability to suppress the immune response to malignant cells, thus
facilitating tumour growth and invasion, and this has fuelled research to reverse these …
facilitating tumour growth and invasion, and this has fuelled research to reverse these …
[HTML][HTML] Vorinostat (SAHA) and breast cancer: an overview
A Wawruszak, L Borkiewicz, E Okon, W Kukula-Koch… - Cancers, 2021 - mdpi.com
Simple Summary Breast cancer (BC) is the most frequent malignancy diagnosed in 2020
worldwide. Despite significant advances in BC therapy, its pathogenesis is still not fully …
worldwide. Despite significant advances in BC therapy, its pathogenesis is still not fully …
Epigenetic modifications in diabetes
RA Kowluru, G Mohammad - Metabolism, 2022 - Elsevier
Diabetes is now considered as a 'silent epidemic'that claims over four million lives every
year, and the disease knows no socioeconomic boundaries. Despite extensive efforts by the …
year, and the disease knows no socioeconomic boundaries. Despite extensive efforts by the …
[HTML][HTML] Post-translational modifications in tumor-associated antigens as a platform for novel immuno-oncology therapies
AK Srivastava, G Guadagnin, P Cappello, F Novelli - Cancers, 2022 - mdpi.com
Simple Summary Tumor-associated antigens (TAAs) are antigens present in tumor cells, but
are also expressed in normal cells. However, TAAs are aberrantly expressed by tumor cells …
are also expressed in normal cells. However, TAAs are aberrantly expressed by tumor cells …
Targeting epigenetics: a novel promise for Alzheimer's disease treatment
D Jeremic, L Jiménez-Díaz, JD Navarro-López - Ageing Research Reviews, 2023 - Elsevier
So far, the search for a cure for Alzheimer Disease (AD) has been unsuccessful. The only
approved drugs attenuate some symptoms, but do not halt the progress of this disease …
approved drugs attenuate some symptoms, but do not halt the progress of this disease …
The zinc-binding group effect: lessons from non-hydroxamic acid vorinostat analogs
S Geurs, D Clarisse, K De Bosscher… - Journal of Medicinal …, 2023 - ACS Publications
Histone deacetylases (HDACs) are enzymes pursued as drug targets in various cancers and
several non-oncological conditions, such as inflammation and neurodegenerative disorders …
several non-oncological conditions, such as inflammation and neurodegenerative disorders …
[HTML][HTML] Prognostic biomarkers in uveal melanoma: The status quo, recent advances and future directions
NJ Lamas, A Martel, S Nahon-Estève, S Goffinet… - Cancers, 2021 - mdpi.com
Simple Summary Although rare, uveal melanoma (UM) is the most common cancer that
develops inside adult eyes. The prognosis is poor, since 50% of patients will develop lethal …
develops inside adult eyes. The prognosis is poor, since 50% of patients will develop lethal …